期刊文献+

重组人骨形态发生蛋白-7工程菌的高密度发酵

High Density Fermentation of Recombinant E. coli with Human Bone Morphogenetic Protein-7
原文传递
导出
摘要 目的建立重组人骨形态发生蛋白-7(rhBMP-7)工程菌的高密度发酵工艺。方法采用摇瓶及发酵罐培养工程菌BL21/pBV221-rhBMP-7,观察不同培养基、乙酸浓度、pH值、诱导时间等对工程菌菌体生长及目的蛋白表达的影响。在优化的发酵条件下培养工程菌,当菌体A600值达100时,42℃升温诱导,并对表达产物进行纯化。结果发酵培养基与LB培养基培养的工程菌目的蛋白的表达量无明显差异;乙酸可明显抑制菌体生长及目的蛋白表达;最适于菌体生长和目的蛋白表达的pH值分别为6.8和7.6;最佳诱导时间为3h。以优化的发酵条件培养的工程菌诱导3h后,目的蛋白的表达量可达菌体总蛋白的34.9%,最终菌体A600值可达139.5;经纯化的目的蛋白纯度可达95%以上。结论已初步建立了rhBMP-7工程菌的高密度发酵工艺。 Objective To develop a high density fermentation procedure for E.coli expressing recombinant human bone morphogenetic protein-7(rhBMP-7).Methods Recombinant E.coli BL21 /pBV221-rhBMP-7 was cultured in shake-flask and in fermenter respectively,and the effects of various factors such as medium,acetic acid concentration,pH value and time for induction on growth of recombinant E.coli and expression of target protein were observed.The recombinant E.coli was cultured under optimized condition,and induced at 42℃ when the A600 reached 100.The expressed product was purified.Results The expression levels of target protein in fermentation medium showed no significant difference with that in LB medium.Acetic acid inhibited the growth of recombinant E.coli and expression of target protein significantly.The optimal pH values for growth of recombinant E.coli and for expression of target protein were 6.8 and 7.6 respectively.The optimal time for induction was 3 h.The expression level of target protein 3 h after induction of the recombinant E.coli cultured under optimized condition reached 34.9% of total somatic protein,while the final A600 reached 139.5.The purity of expressed protein was more than 95% after purification.Conclusion A high density fermentation procedure for recombinant E.coli BL21 /pBV221-rhBMP-7 was preliminarily developed.
出处 《中国生物制品学杂志》 CAS CSCD 2010年第5期503-506,共4页 Chinese Journal of Biologicals
基金 国家高新技术发展计划项目(863)(2003AA2Z3532)
关键词 骨形态发生蛋白-7 高密度发酵 指数补料 Bone morphogenetic protein-7 High density fermentation Fed-batch
  • 相关文献

参考文献16

  • 1Bessa PC, Casal M, Reis RL. Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med, 2008, 2 ( 1 ): 1-13.
  • 2Bessa PC, Casal M, Reis RL. Bone morpbogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med, 2008, 2 (2-3): 81-96.
  • 3Choi JH, Keum KC, Lee SY. Production of recombinant proteins by high cell density culture of Escherichia colt. Chem Eng Sci, 2006, 61 (3): 876-885.
  • 4孙杰,卞翠荣,王世立,韩金祥,张维东,李国菊.重组人骨形态发生蛋白-7复合体对牙槽骨再生的影响[J].中国生物制品学杂志,2007,20(4):282-284. 被引量:2
  • 5王国栋,王世立,韩金祥,张翠,张更林,车婧.表达重组人骨形态发生蛋白-7工程菌的发酵及表达产物的纯化[J].生物技术通讯,2006,17(3):345-348. 被引量:4
  • 6Korz DJ, Rinas U, Hellmuth K, et al. Simple fed-batch technique for high cell density cultivation of Escherichia coli. J Biotechnol, 1995, 39 (1): 59-65.
  • 7Vallejo LF, Brokelmann M, Marten S, et al. Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coll. J Biotechnol, 2002, 94 (2): 185-194.
  • 8Wolfe AJ. The acetate switch. Microbiol Mol Biol Rev, 2005, 69 (1): 12-50.
  • 9Babaeipour V, Shojaosadati SA, Robatjazi SM, et al. Over-production of human interferon-γ by HCDC of recombinant Escherichia coll. Process Biochemistry, 2007, 42( 1 ): 112-117.
  • 10Babaeipour V, Shojaosadati SA, Khalilzadeh R, et al. A proposed feeding strategy for the overproduction of recombinant proteins in Escherichia coll. Biotechnol Appl Biochem, 2008, 49(Pt 2): 141- 147.

二级参考文献17

  • 1吴迎涛,钟德钰.BMP复合体在牙槽骨缺损修复中的作用[J].青岛大学医学院学报,2004,40(4):297-299. 被引量:4
  • 2高宁,李宁毅,贾暮云,商红国.rhBMP-2与聚乳酸复合体植入犬拔牙创对牙槽骨再生的影响[J].齐鲁医学杂志,2004,19(6):481-483. 被引量:2
  • 3王国栋,王世立,韩金祥.骨形态发生蛋白-7的研究进展[J].医学分子生物学杂志,2004,1(6):382-385. 被引量:6
  • 4商红国,唐建民,李宁毅.促使骨组织再生的生物活性材料[J].齐鲁医学杂志,2005,20(6):555-556. 被引量:1
  • 5Asahina I,Sampath TK,Hauschka PV.Human osteogenic protein-1 induces chondroblastic,osteoblastic,and/or adipocytic differentiation of clonal murine target cells[J].Exp Cell Res,1996,222(1):38
  • 6Vaccaro AR,Patel T,Fischgrund J,et al.A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions[J].Eur Spine J,2003,12:495
  • 7McGee MA,Findlay DM,Howie DW,et al.The use of OP-1 in femoral impaction grafting in a sheep model[J].J Orthopaedic Research,2004,22:1008
  • 8Bomback DA,Grauer JN,Lugo R,et al.Comparison of posterolateral lumbar fusion rates of grafton putty and OP1 putty in an athymic rat model[J].Spine,2004,29(15):1612
  • 9Bradford MM.A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding[J].Anal Biochem,1976,72:248
  • 10Wozney JM.Overview of bone morphogenetic proteins[J].Spine,2002,27(16 Suppl 1):S2

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部